Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2019 Mar 27;1(1):10–18. doi: 10.1016/j.ajogmf.2019.03.006

Table 1:

Baseline Characteristics, n (%) or mean (SD) (N=137)

Placebo (n=67) Nicotine (n=70) P-Value*
Site
 Baystate Medical Center 44 (66%) 45 (64%) 1.000
 Hartford Hospital 23 (34%) 25 (36%)
Age in Years 28.24 (6.30) 26.97 (5.45) 0.257
Cigarettes smoked per day 8.04 (4.59) 8.66 (4.71) 0.321
FTCDa score 4.27 (2.00) 4.25 (1.79) 0.922
Race/Ethnicity 0.378
 Hispanic or Latino 33 (50%) 28 (41%)
 Non Hispanic, White 25 (38%) 26 (38%)
 Non Hispanic, Black 8 (12%) 14 (20%)
 Other 0 (0%) 1 (1%)
Highest level of education completed 0.836
 Grade school completed 20 (30%) 18 (26%)
 High school completed 31 (46%) 36 (51%)
 College or post-college completed 16 (24%) 16 (23%)
Insurance 0.745
 Public 63 (94%) 64 (91%)
 Private 4 (6%) 6 (9%)
Opioid Dependence Treatment 13 (19%) 12 (17%) 0.826
Medical History
 Depression or anxiety 39 (58%) 44 (63%) 0.604
 Substance abuse 23 (34%) 26 (37%) 0.859
 Progesterone use 5 (7%) 6 (9%) 0.999
Pregnancy
 Number of previous (median) pregnancies 2 2 0.733
 Gestational age at entry (week) 17.38 (3.88) 17.54 (3.91) 0.880
 Gestational age starting inhaler use 19.39 (4.10) 19.73 (4.08) 0.629
 History of preterm delivery 6 (9%) 15 (21%) 0.057
 First pregnancy 14 (21%) 12 (17%) 0.665
Motivation to quit smoking (0–10) 8.76 (1.53) 8.13 (1.61) 0.016
Self-efficacy to quit smoking (0–10) 7.54 (2.1) 6.90 (2.37) 0.135
*

Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous/discrete variables.

a

Fagertsrom test for nicotine dependence